Fate Therapeutics Statistics
Total Valuation
FATE has a market cap or net worth of $163.19 million. The enterprise value is $7.28 million.
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
FATE has 115.33 million shares outstanding. The number of shares has increased by 13.79% in one year.
| Current Share Class | 115.33M |
| Shares Outstanding | 115.33M |
| Shares Change (YoY) | +13.79% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 1.44% |
| Owned by Institutions (%) | 62.61% |
| Float | 100.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.01 |
| Forward PS | 28.14 |
| PB Ratio | 0.57 |
| P/TBV Ratio | 0.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.04, with a Debt / Equity ratio of 0.31.
| Current Ratio | 8.04 |
| Quick Ratio | 7.89 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -52.11% and return on invested capital (ROIC) is -26.43%.
| Return on Equity (ROE) | -52.11% |
| Return on Assets (ROA) | -24.66% |
| Return on Invested Capital (ROIC) | -26.43% |
| Return on Capital Employed (ROCE) | -51.80% |
| Revenue Per Employee | $46,796 |
| Profits Per Employee | -$947,635 |
| Employee Count | 181 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.57% in the last 52 weeks. The beta is 2.33, so FATE's price volatility has been higher than the market average.
| Beta (5Y) | 2.33 |
| 52-Week Price Change | -52.57% |
| 50-Day Moving Average | 1.22 |
| 200-Day Moving Average | 1.17 |
| Relative Strength Index (RSI) | 44.90 |
| Average Volume (20 Days) | 2,964,179 |
Short Selling Information
The latest short interest is 7.54 million, so 6.54% of the outstanding shares have been sold short.
| Short Interest | 7.54M |
| Short Previous Month | 7.99M |
| Short % of Shares Out | 6.54% |
| Short % of Float | 7.48% |
| Short Ratio (days to cover) | 2.65 |
Income Statement
In the last 12 months, FATE had revenue of $8.47 million and -$171.52 million in losses. Loss per share was -$1.45.
| Revenue | 8.47M |
| Gross Profit | -106.81M |
| Operating Income | -177.64M |
| Pretax Income | -171.52M |
| Net Income | -171.52M |
| EBITDA | -161.61M |
| EBIT | -177.64M |
| Loss Per Share | -$1.45 |
Full Income StatementBalance Sheet
The company has $222.83 million in cash and $81.33 million in debt, giving a net cash position of $141.50 million or $1.23 per share.
| Cash & Cash Equivalents | 222.83M |
| Total Debt | 81.33M |
| Net Cash | 141.50M |
| Net Cash Per Share | $1.23 |
| Equity (Book Value) | 261.36M |
| Book Value Per Share | 2.28 |
| Working Capital | 201.72M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$115.61 million and capital expenditures -$3.15 million, giving a free cash flow of -$118.77 million.
| Operating Cash Flow | -115.61M |
| Capital Expenditures | -3.15M |
| Free Cash Flow | -118.77M |
| FCF Per Share | -$1.03 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -2,097.24% |
| Pretax Margin | -2,025.05% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FATE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.79% |
| Shareholder Yield | -13.79% |
| Earnings Yield | -115.29% |
| FCF Yield | -79.83% |
Analyst Forecast
The average price target for FATE is $3.92, which is 177.03% higher than the current price. The consensus rating is "Buy".
| Price Target | $3.92 |
| Price Target Difference | 177.03% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 56.47% |
| EPS Growth Forecast (5Y) | -13.23% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FATE has an Altman Z-Score of -5.06 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.06 |
| Piotroski F-Score | 1 |
